Amerigas Partners Limited Part (APU) Shareholder Roffman Miller Associates Upped Holding by $472,365 as Valuation Declined; Veracyte (VCYT) Holder Broadfin Capital Trimmed Its Position by $1.61 Million

December 7, 2017 - By Kurt Siggers

Kevin Kotler decreased its stake in Veracyte Inc (VCYT) by 12.23% based on its latest 2017Q2 regulatory filing with the SEC. Broadfin Capital Llc sold 201,700 shares as the company’s stock rose 2.87% with the market. The hedge fund run by Kevin Kotler held 1.45M shares of the health care company at the end of 2017Q2, valued at $12.05M, down from 1.65M at the end of the previous reported quarter. Broadfin Capital Llc who had been investing in Veracyte Inc for a number of months, seems to be less bullish one the $214.11M market cap company. The stock decreased 0.94% or $0.06 during the last trading session, reaching $6.29. About 170,195 shares traded or 3.11% up from the average. Veracyte, Inc. (NASDAQ:VCYT) has risen 56.46% since December 7, 2016 and is uptrending. It has outperformed by 39.76% the S&P500.

Roffman Miller Associates Inc increased its stake in Amerigas Partners Limited Part (APU) by 13.69% based on its latest 2017Q2 regulatory filing with the SEC. Roffman Miller Associates Inc bought 10,497 shares as the company’s stock declined 9.65% while stock markets rallied. The institutional investor held 87,184 shares of the consumer services company at the end of 2017Q2, valued at $3.94M, up from 76,687 at the end of the previous reported quarter. Roffman Miller Associates Inc who had been investing in Amerigas Partners Limited Part for a number of months, seems to be bullish on the $4.14 billion market cap company. The stock decreased 0.76% or $0.34 during the last trading session, reaching $44.55. About 228,067 shares traded or 32.10% up from the average. AmeriGas Partners, L.P. (NYSE:APU) has declined 1.59% since December 7, 2016 and is downtrending. It has underperformed by 18.29% the S&P500.




Investors sentiment decreased to 1.88 in 2017 Q2. Its down 0.45, from 2.33 in 2017Q1. It worsened, as 7 investors sold VCYT shares while 19 reduced holdings. 15 funds opened positions while 34 raised stakes. 21.14 million shares or 2.38% more from 20.65 million shares in 2017Q1 were reported. Spark Invest Mgmt stated it has 101,800 shares. Invesco Limited reported 10,893 shares stake. Northwestern Mutual Wealth Mgmt Com reported 0% in Veracyte, Inc. (NASDAQ:VCYT). Meeder Asset stated it has 803 shares. California Employees Retirement Systems accumulated 0% or 148,600 shares. Gsa Prtnrs Ltd Liability Partnership reported 0.02% in Veracyte, Inc. (NASDAQ:VCYT). 49,500 were reported by Numeric Invsts Ltd Llc. Tower Rech Capital Ltd Liability Com (Trc) reported 10,907 shares or 0.01% of all its holdings. 256,978 are owned by State Street Corp. Grandeur Peak Advsr Limited Liability Com holds 328,039 shares or 0.39% of its portfolio. Savings Bank Of America Corp De stated it has 1,442 shares or 0% of all its holdings. Price T Rowe Associates Md invested in 0% or 21,492 shares. Panagora Asset Management, a Massachusetts-based fund reported 4,489 shares. Manufacturers Life Ins The reported 22,961 shares. 82,193 were reported by Denver Invest Advsrs Ltd Liability Corporation.

Among 6 analysts covering Veracyte (NASDAQ:VCYT), 4 have Buy rating, 0 Sell and 2 Hold. Therefore 67% are positive. Veracyte had 11 analyst reports since August 14, 2015 according to SRatingsIntel. On Friday, December 18 the stock rating was initiated by Cantor Fitzgerald with “Buy”. As per Tuesday, November 29, the company rating was upgraded by Janney Capital. As per Friday, August 14, the company rating was maintained by BTIG Research. The firm earned “Neutral” rating on Tuesday, November 7 by Janney Capital. The stock of Veracyte, Inc. (NASDAQ:VCYT) earned “Hold” rating by Piper Jaffray on Tuesday, November 7. Leerink Swann maintained Veracyte, Inc. (NASDAQ:VCYT) on Tuesday, November 7 with “Outperform” rating. On Friday, August 14 the stock rating was maintained by Piper Jaffray with “Overweight”.

Broadfin Capital Llc, which manages about $1.26 billion and $823.03 million US Long portfolio, upped its stake in Progenics Pharmaceuticals In (NASDAQ:PGNX) by 750,000 shares to 1.00M shares, valued at $6.79 million in 2017Q2, according to the filing. It also increased its holding in Cogentix Med Inc by 340,771 shares in the quarter, for a total of 1.09 million shares, and has risen its stake in Aratana Therapeutics Inc (NASDAQ:PETX).

Analysts await Veracyte, Inc. (NASDAQ:VCYT) to report earnings on March, 7. They expect $-0.19 earnings per share, down 35.71% or $0.05 from last year’s $-0.14 per share. After $-0.21 actual earnings per share reported by Veracyte, Inc. for the previous quarter, Wall Street now forecasts -9.52% EPS growth.

More notable recent Veracyte, Inc. (NASDAQ:VCYT) news were published by: Streetinsider.com which released: “Piper Jaffray Downgrades Veracyte, Inc (VCYT) to Neutral” on November 07, 2017, also Streetinsider.com with their article: “Veracyte, Inc (VCYT) PT Lowered to $9 at Leerink Partners” published on November 07, 2017, Livetradingnews.com published: “Veracyte Inc (NASDAQ:VCYT) Stock Oversold” on November 20, 2017. More interesting news about Veracyte, Inc. (NASDAQ:VCYT) were released by: Businesswire.com and their article: “Veracyte Announces Publication of Data Confirming Analytical Validity of …” published on November 28, 2017 as well as Livetradingnews.com‘s news article titled: “Veracyte Inc (NASDAQ:VCYT) Waiting for an Entry” with publication date: December 01, 2017.

Roffman Miller Associates Inc, which manages about $833.24 million and $729.83M US Long portfolio, decreased its stake in Technipfmc by 46,452 shares to 39,283 shares, valued at $1.07 million in 2017Q2, according to the filing.

Among 6 analysts covering AmeriGas Partners LP (NYSE:APU), 1 have Buy rating, 3 Sell and 2 Hold. Therefore 17% are positive. AmeriGas Partners LP had 11 analyst reports since August 20, 2015 according to SRatingsIntel. The stock of AmeriGas Partners, L.P. (NYSE:APU) has “Hold” rating given on Monday, October 16 by Jefferies. The company was downgraded on Friday, February 3 by Bank of America. On Friday, June 10 the stock rating was downgraded by UBS to “Sell”. Janney Capital reinitiated the shares of APU in report on Thursday, May 26 with “Buy” rating. Jefferies maintained the shares of APU in report on Thursday, June 22 with “Hold” rating. JP Morgan maintained AmeriGas Partners, L.P. (NYSE:APU) on Monday, November 2 with “Neutral” rating. UBS maintained the shares of APU in report on Thursday, November 19 with “Neutral” rating. Barclays Capital maintained AmeriGas Partners, L.P. (NYSE:APU) on Thursday, August 4 with “Underweight” rating. On Saturday, August 29 the stock rating was downgraded by TheStreet to “Buy”.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.